Effects of nanoliposomal irinotecan (nal-IRI;MM-398) +/- 5-Fluorouracil und leucavorin (5-FU/LV) on quality of life (QoL) in NAPOLI-1: a phase 3 study in patients (pts) with metastatic pancreatic adenocarcinoma (mPAC) previously treated with gemcitabine-based therapy.
Siveke, J Cubillo, A Blanc, J Melisi, D Von Hoff, D Wang-Gillam, A Chen, L Becker, C Mamlouk, K Belanger, B
Siveke, J
Cubillo, A
Blanc, J
Melisi, D
Von Hoff, D
Wang-Gillam, A
Chen, L
Becker, C
Mamlouk, K
Belanger, B
Citations
Altmetric:
Abstract
Description
Date
2017
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Effects of nanoliposomal irinotecan (nal-IRI;MM-398) +/- 5-Fluorouracil und leucavorin (5-FU/LV) on quality of life (QoL) in NAPOLI-1: a phase 3 study in patients (pts) with metastatic pancreatic adenocarcinoma (mPAC) previously treated with gemcitabine-based therapy. 2017, 40:259-259 Oncol Res Treat